Levels of the proinflammatory cytokine TNF-α have been found to be increased in cerebrospinal fluid (CSF) in treatment-resistant CM patients [87], while levels of somatostatin and glial cell line-derived neurotrophic factor (GDNF) were decreased in the CSF of patients with CM [88]. Here, GDNF is linked to cutaneous mastocytosis.